View in EDS HTML Full Text PDF Full Text

Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies.

Saved in:
Bibliographic Details
Title: Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies.
Authors: Craig, Timothy J.1 (AUTHOR) tcraig@pennstatehealth.psu.edu, Zaragoza-Urdaz, Rafael H.2 (AUTHOR), Li, H. Henry3 (AUTHOR), Yu, Ming4 (AUTHOR), Ren, Hong5 (AUTHOR), Juethner, Salomé4 (AUTHOR), Anderson, John6 (AUTHOR)
Source: Allergy, Asthma & Clinical Immunology. 9/24/2022, Vol. 18 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17101484
DOI:10.1186/s13223-022-00721-y